Strengthening Acino's presence and capabilities in the Middle East. Over 100 Pharmax employees and its UAE-based manufacturing site to enhance our expertise and expanding portfolio in the region.
Acino, today announces its recognition and support of World Health Organization’s World Antimicrobial Awareness Week (WAAW) 2022.
A global vision translated into a local approach has made Acino synonymous with quality and affordable healthcare to benefit the healthy development of the South African nation.
Acino, will today commence an awareness programme in recognition of the upcoming World Heart Day on 29 September, 2022 and the work of the World Heart Federation to raise awareness of cardiovascular disease (CVD).
Acino has signed an exclusive licensing agreement with Bioprojet, to register, market, commercialise, and distribute an innovative medicine in Saudi Arabia, with potential expansion to other countries in the Middle East.
Established in Switzerland since 1836 and with a proven track record of high quality products for many years the deeply rooted high standard quality pledge is reflected in all of Acino’s activities.
When you choose Acino, you are choosing quality you can rely on.
Our Mission is to develop, manufacture and commercialize Swiss quality pharmaceuticals for the benefit of patients.
Growing fast and making an impact for patients in emerging markets.
Who we are, what we stand for and are signposts for what we need to aspire to in our everyday actions.
